New York, New York

Sexual Health, HIV Prevention, and Primary Care in 2019

Registration Details

  • On-site Registration: $105.00 (USD)
  • On-site Registration ends: Thursday, September 12, 2019
  • On-site Fellow/Student Registration: $30.00 (USD)
  • On-site Fellow/Student Registration ends: Thursday, September 12, 2019
  • Early Registration: $75.00 (USD)
  • Early Registration ends: Thursday, August 29, 2019
  • Pregistration: $95.00 (USD)
  • Pregistration ends: Monday, September 9, 2019
  • Fellow/Student: $30.00 (USD)
  • Fellow/Student ends: Monday, September 9, 2019

Course Chairs

Roy M. Gulick, MD, MPH
Weill Cornell Medicine
Jeanne M. Marrazzo, MD, MPH
University of Alabama at Birmingham


September 12, 2019 - 8:30 AM


September 12, 2019 - 4:00 PM

Add to iCal Calendar


New York Law School
185 West Broadway
New York
New York
United States

Sexual Health, HIV Prevention, and Primary Care in 2019, a new educational effort from the IAS–USA, will address the rising epidemic of sexually transmitted infections (STIs) in the United States. This course will address the best practices for maintaining sexual health among adolescents and adults with or at risk for HIV infection. This includes diagnosis, management, and prevention of STIs with a particular focus on syphilis. The course will also address other key factors in maintaining sexual health such as HIV prevention strategies, including preexposure prophylaxis (PrEP), antiretroviral therapy during conception and pregnancy, and appropriate vaccines against preventable diseases. Information will be presented through a mix of didactic lectures and clinically relevant cases developed by an expert faculty of STI and HIV/AIDS clinicians and researchers.

The Sexual Health, HIV Prevention, and Primary Care in 2019 course is presented by IAS–USA and conducted in collaboration with the Northeast/Caribbean AIDS Education and Training Center (NECA AETC).

Assessment of Needs

The incidence of sexually transmitted infections (STIs) in the United States continues to increase at an alarming rate. In 2017, there were 1.7 million cases of chlamydia, 555,608 cases of gonorrhea, and 101,567 cases of syphilis (an 80% increase in syphilis cases from 2013 to 2017). Half of all new STI diagnoses are in people 15 to 24 years old, though this group represents only 25% of the sexually active population. With the increase in STIs there is a need for implementing preventative and management strategies on a larger scale that will require broadening responsibility for STI and HIV prevention strategies to include primary care clinicians and other clinicians who see persons at risk. Expanding this effort to better manage sexual health requires a widespread educational effort aimed at recognizing, diagnosing, and treating STIs as well as preventing HIV infection.1

1O’Neill Institute for National and Global Health Law. Quick Take: The US STI Crisis. 2019.

Learning Objectives

After participating in the activity, learners will be better able to:

  • Describe the emerging epidemiology, clinical presentations and management of the most common sexually transmitted infections (STIs)
  • Describe the fundamentals of diagnosis staging, serology, and treatment of syphilis
  • Initiate and monitor HIV prevention strategies, including preexposure prophylaxis (PrEP), among those at risk for HIV infection
  • Apply newly available data to antiretroviral strategies for the management of established HIV infection in the context of conception and pregnancy
  • Apply newly available data to provide specific immunization guidance based on an individual’s immunologic status and assessed risk

Conflicts of Interest

In the interest of maintaining the independence of its CME activities, and in accordance with the policies of the Accreditation Council for Continuing Medical Education (ACCME), the IAS–USA requires all persons with control of content (eg, faculty, IAS–USA Board members, and program staff) to disclose any financial relationships that they or their spouses or partners have had with commercial companies within the past 12 months. Any real or apparent conflicts of interest of those parties are resolved prior to the CME activity being delivered. Individuals who refuse to disclose financial interests may not participate in an IAS–USA CME activity.

The ACCME defines a commercial interest as “any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests – unless the provider of clinical service is owned, or controlled by, an ACCME-defined commercial interest.”


Who Should Attend

This course is designed for primary care clinicians, HIV specialists, and other clinicians who are responsible for the prevention and management of STIs and HIV.

This activity is also relevant to nurse practitioners, registered nurses, physician assistants, registered pharmacists, and other health professionals.

If you are found to be ineligible to attend this activity, the IAS–USA reserves the right to cancel your registration and refund your fee (if applicable).

Cancellation Policy

Cancellation requests must be made 8 or more days before the date of an activity. All refunds will be processed minus a $15.00 processing charge. Regrettably, any cancellation requests received within a week before the course will not be eligible for the partial refund. THERE ARE NO SUBSTITUTION ALLOWED.

Continuing Education Credits

CME Credits

The International Antiviral Society–USA (IAS–USA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The IAS–USA designates this live activity for a maximum of 6.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


ABIM MOC Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Nursing Credits

Educational Review Systems is an recognized approver of continuing nursing education by the Alabama State Nursing Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.  Provider # 5-115.  This program is approved for 6.25 hours of continuing nursing education.

Educational Review Systems is also approved for nursing continuing education by the state of California, the state of Florida and the District of Columbia.

Pharmacy Credits

Accreditation Council for Pharmacy Education logoEducational Review Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. Participants of the session who complete the evaluation and provide accurate NABP e-Profile information will have their credit for 6.25 contact hours (0.625 CEU) submitted to CPE Monitor as early as 14 days after the event and no later than 60 days after the event. Please know that if accurate e-Profile information is not provided within 60 days of the event, credit cannot be claimed after that time. The participant is accountable for verifying the accurate posting of CE credit to their CPE Monitor account within 60 days.
UAN  # 0761-9999-19-219-L01-P

AAFP Credits

This Live activity, Sexual Health, HIV Prevention, and Primary Care in 2019, with a beginning date of 09/12/2019, has been reviewed and is acceptable for up to 6.00 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Grant Support

This activity is part of the IAS–USA national educational effort that is funded, in part, by charitable contributions from commercial companies. Per IAS–USA policy, any effort that uses commercial grants must receive grants from several companies with competing products. Funds are pooled and distributed to activities at the sole discretion of the IAS–USA. Grantors have no input into any activity, including its content, development, or selection of topics or speakers. Food and beverages at IAS–USA events are purchased with registration fees, not with grant support money.

Gilead Sciences, Inc
ViiV Healthcare

Merck & Co, Inc


Additional support has been provided by

Physician Payment Sunshine Act (“Sunshine Act” or “Open Payment”)

In 2014, the Physician Payment Sunshine Act (“Sunshine Act” or “Open Payments”), a provision of the Affordable Care Act, was developed. According to the Centers for Medicare and Medicaid Services (CMS): “Open Payments is a national disclosure program that promotes transparency by publishing the financial relationships between the medical industry and healthcare providers (physicians and hospitals) on a publicly accessible website developed by CMS.” Until recently, CME activities that receive commercial support have been exempt from reporting payments for goods such as hosted meals. Attendee registration fees are used for all food and beverage expenses provided by IAS–USA at the activity.